Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Recent advancements in comprehensive genetic analyses for human hepatocellular carcinoma.

Nishida N, Kudo M.

Oncology. 2013;84 Suppl 1:93-7. doi: 10.1159/000345897. Epub 2013 Feb 20. Review.

PMID:
23428866
2.

Early molecular and genetic determinants of primary liver malignancy.

Feitelson MA, Pan J, Lian Z.

Surg Clin North Am. 2004 Apr;84(2):339-54. Review.

PMID:
15062649
3.

The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.

Matsuzaki Y, Sato M, Saito Y, Karube M, Doy M, Shoda J, Abei M, Tanaka N, Hadama T, Kinoshita M.

J Exp Clin Cancer Res. 1999 Sep;18(3):379-89. Erratum in: J Exp Clin Cancer Res 2000 Mar;19(1):125.

PMID:
10606185
4.

[Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis].

Xue KX.

Ai Zheng. 2005 Jun;24(6):757-68. Review. Chinese.

PMID:
15946497
5.

Comprehensive genome sequencing of the liver cancer genome.

Nakagawa H, Shibata T.

Cancer Lett. 2013 Nov 1;340(2):234-40. doi: 10.1016/j.canlet.2012.10.035. Epub 2012 Nov 8. Review.

PMID:
23142287
6.

Next generation sequencing reveals genetic landscape of hepatocellular carcinomas.

Li S, Mao M.

Cancer Lett. 2013 Nov 1;340(2):247-53. doi: 10.1016/j.canlet.2012.09.027. Epub 2012 Oct 12. Review.

PMID:
23063663
7.

Recent advances in the research of hepatitis B virus-related hepatocellular carcinoma: epidemiologic and molecular biological aspects.

Kao JH, Chen PJ, Chen DS.

Adv Cancer Res. 2010;108:21-72. doi: 10.1016/B978-0-12-380888-2.00002-9. Review.

PMID:
21034965
8.

Genetic and epigenetic events in human hepatocarcinogenesis.

Kondoh N, Wakatsuki T, Hada A, Shuda M, Tanaka K, Arai M, Yamamoto M.

Int J Oncol. 2001 Jun;18(6):1271-8. Review.

PMID:
11351262
9.

Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population.

Li S, Deng Y, Chen ZP, Huang S, Liao XC, Lin LW, Li H, Peng T, Qin X, Zhao JM.

Infect Genet Evol. 2011 Dec;11(8):2083-8. doi: 10.1016/j.meegid.2011.09.025. Epub 2011 Oct 12.

PMID:
22019522
10.

Exome capture sequencing reveals new insights into hepatitis B virus-induced hepatocellular carcinoma at the early stage of tumorigenesis.

Chen Y, Wang L, Xu H, Liu X, Zhao Y.

Oncol Rep. 2013 Oct;30(4):1906-12. doi: 10.3892/or.2013.2652. Epub 2013 Aug 2.

PMID:
23912677
11.

Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development.

Hu L, Zhai X, Liu J, Chu M, Pan S, Jiang J, Zhang Y, Wang H, Chen J, Shen H, Hu Z.

Hepatology. 2012 May;55(5):1426-31. doi: 10.1002/hep.24799. Epub 2012 Mar 16.

PMID:
22105689
12.

Genetic aspects of hepatocellular carcinogenesis.

Ozturk M.

Semin Liver Dis. 1999;19(3):235-42. Review.

PMID:
10518303
13.

Novel mouse models of hepatocarcinogenesis with stepwise accumulation of genetic alterations.

Kim SK, Marusawa H, Eso Y, Chiba T, Kudo M.

Dig Dis. 2013;31(5-6):454-8. doi: 10.1159/000355244. Epub 2013 Nov 21. Review.

14.

Mutational complex genotype of the hepatitis B virus X /precore regions as a novel predictive marker for hepatocellular carcinoma.

Jang JW, Chun JY, Park YM, Shin SK, Yoo W, Kim SO, Hong SP.

Cancer Sci. 2012 Feb;103(2):296-304. doi: 10.1111/j.1349-7006.2011.02170.x. Epub 2012 Jan 19.

15.

Hepatitis B and alterations of the p53 tumor suppressor gene in hepatocellular carcinoma.

Goldblum JR, Bartos RE, Carr KA, Frank TS.

Am J Surg Pathol. 1993 Dec;17(12):1244-51.

PMID:
8238731
16.

Genetic alterations and oncogenic pathways in hepatocellular carcinoma.

Lévy L, Renard CA, Wei Y, Buendia MA.

Ann N Y Acad Sci. 2002 Jun;963:21-36.

PMID:
12095925
17.
18.

Association between epidermal growth factor 61A/G polymorphism and hepatocellular carcinoma susceptibility in Chinese patients.

Li Y, Xie Q, Lu F, Zhao J, Mao P, Li Z, Liu S, Zhuang H.

Liver Int. 2010 Jan;30(1):112-8. doi: 10.1111/j.1478-3231.2009.02134.x. Epub 2009 Oct 15.

PMID:
19840254
19.

Large-scale analysis of the genetic and epigenetic alterations in hepatocellular carcinoma from Southeast China.

Su H, Zhao J, Xiong Y, Xu T, Zhou F, Yuan Y, Zhang Y, Zhuang SM.

Mutat Res. 2008 May 10;641(1-2):27-35. doi: 10.1016/j.mrfmmm.2008.02.005. Epub 2008 Feb 14.

PMID:
18358501
20.

Genetic and epigenetic signatures in human hepatocellular carcinoma: a systematic review.

Nishida N, Goel A.

Curr Genomics. 2011 Apr;12(2):130-7. doi: 10.2174/138920211795564359.

Supplemental Content

Support Center